Sientra - About the company
Sientra is a public company based in Santa Barbara (United States), founded in 2007 by . It operates as a Products for plastic surgery/ aesthetics. Sientra has raised $150M in funding. The company has 35 active competitors, including 11 funded and 7 that have exited. Its top competitors include companies like Establishment Labs, GC Aesthetics and BioAesthetics.
Company Details
Sientra develops and markets products focusing on the plastic surgery and aesthetics market. Its portfolio includes breast implants, breast tissue expanders, body contouring, facial implants, etc. The company went public in Oct 2014.
Key Metrics
Founded Year
2007
Location
Santa Barbara, United States
Stage
Public
Total Funding
in 3 rounds
Latest Funding Round
Investors
Ranked
1st among
Employee Count
as on Dec 31, 2022
Similar Companies
Exit Details
Public
Legal entities associated with Sientra
Sientra is associated with 2 legal entities given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
---|---|---|---|---|
Aug 28, 2003 | - | 351 | 723 | |
Dec 26, 999 | - | 552 | 788 |
Get your free copy of Sientra's company profile
Sientra's funding and investors
Sientra has raised a total funding of $150M over 3 rounds. Its first funding round was on Apr 18, 2007. Its latest funding round was a Post IPO round on Mar 11, 2020 for $60M. 1 investor participated in its latest round, which include Goldman Sachs, Abingworth, Orbimed and Deerfield.
Sientra has 6 institutional investors including Goldman Sachs, Abingworth and Orbimed.
Here is the list of recent funding rounds of Sientra:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
---|---|---|---|---|---|
Mar 11, 2020 | $60M | Post IPO | 5342649 | 1741358 | |
Mar 28, 2012 | $65M | Series C | 1318593 | 3918044 | Abingworth, Blackstone, and |
Apr 18, 2007 | $85M | Series B | 5993602 | 1072719 | Orbimed, Goldman Sachs, and |
View details of Sientra's funding rounds and investors
Sientra's founders and board of directors
The founders of Sientra is . is the CEO of Sientra.
View details of Sientra's Founder profiles and Board Members
Sientra's employee count trend
Sientra has 304 employees as of Dec 22. The total employee count is 367.7% more than what it was in Dec 21. Here is Sientra's employee count trend over the years:Sientra's Competitors and alternates
Top competitors of Sientra include Establishment Labs, GC Aesthetics and BioAesthetics. Here is the list of Top 10 competitors of Sientra, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
---|---|---|---|---|---|
1st | 2007, Santa Barbara (United States), Public | Products for plastic surgery/ aesthetics | $150M | Goldman Sachs, AbingworthÌý&²¹³¾±è;Ìý | 57/100 |
2nd | Establishment Labs 2010, Alajuela (Costa Rica), Public | Developer of silicone-filled breast and body shaping implants | $121M | Perceptive Advisors, RTW InvestmentsÌý&²¹³¾±è;Ìý | 69/100 |
3rd | GC Aesthetics 2007, Dublin (Ireland), Series E | Developer of silicone breast implants for breast reconstruction | $233M | Orbimed, Montreux Equity PartnersÌý&²¹³¾±è;Ìý | 63/100 |
4th | BioAesthetics 2015, New Orleans (United States), Series A | Developer of a tissue-engineered nipple-areolar complex | $7.4M | National Science Foundation, America’s Seed FundÌý&²¹³¾±è;Ìý | 51/100 |
5th | Ideal Implant 2006, Dallas (United States), Acquired | Structured saline-filled breast implant | $17M | 49/100 | |
6th | AirXpanders 2006, Mountain View (United States), Public | Tissue exapnder for post mastectomy reconstructive surgery | $36.1M | Vivo Capital, Western Technology InvestmentÌý&²¹³¾±è;Ìý | 47/100 |
7th | Mpathy Medical Devices 2003, Raynham (United States), Acquired | Surgical meshes for urinary incontinence in women | $5.4M | 41/100 | |
8th | ![]() Lattice Medical 2017, Loos (France), Series A | Provider of 3D-printed technology for soft tissue reconstruction | $13.5M | EIC Fund, Nord France AmorquageÌý&²¹³¾±è;Ìý | 40/100 |
9th | Prostheses for a natural breast reconstruction | $16.7M | , EIC FundÌý&²¹³¾±è;Ìý | 40/100 | |
10th | ![]() VivArt-X 2022, Eindhoven (Netherlands), Seed | Developer of regenerative materials for women health | $2.23M | BOM, Ìý&²¹³¾±è;Ìý | 39/100 |
Looking for more details on Sientra's competitors? Click to see the top ones
Sientra's Investments and acquisitions
Sientra has made no investments or acquisitions yet.
Reports related to Sientra
Here is the latest report on Sientra's sector:
View
News related to Sientra
Media has covered Sientra for 1 event in last 1 year.
•
•
The Wall Street Journal•Feb 13, 2024•Sientra
•
Medical Product Outsourcing•Oct 27, 2023•Cutera, Sientra, Spinal Elements, Johnson & Johnson MedTech and 2 others
•
GlobeNewswire•Jun 09, 2023•Sientra
•
Seeking Alpha•May 17, 2023•Sientra
•
•
•
Seeking Alpha•Jan 20, 2023•Sientra
•
Seeking Alpha•Dec 14, 2022•Sientra
•
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies
212K+ Investors
580K+ Funding Rounds
207K+ Acquisitions
2.9K+ Sectors
57K+ Business Models








Are you a Founder ?
FAQ's about Sientra
Explore our recently published companies
- energy-storagesystem - Guangzhou based, Unfunded company
- Zed Black - Indore based, 2012 founded, Unfunded company
- RispostaGlobal - Hyderabad based, 2021 founded, Unfunded company
- Al Mutawa Certified - Kuwait based, 1951 founded, Unfunded company
- ChatGenius - Dhaka based, 2011 founded, Unfunded company
- Zantus Lifesciences - Mumbai based, 2024 founded, Unfunded company